Preman Kumarathurai, MD PhD MSc

❤️❤️ #ESCCongress2023 with colleagues from @CardResearchOuh❤️❤️ @MassarOmard @LouiLinde @pkumarathurai #JoinForcesWithESC #ESCCongress #DCS_ESC23

What an incredible day! 🎓 Graduated from @UniofOxford with this fabulous bunch : Inaugural cohort of the @Oxford_NDPH MSc in Clinical Trials! We made it, guys! 🙌

Dinner with my amazing classmates and the Godfather of randomized trials, Sir Richard Peto, at @UniofOxford @pkumarathurai @BoldiKovacsMD @JulePinter @willkidney @FH_Verbrugge @aayshacader @cristina_gavina @escardio @CopCard @CIRL_DK @BiomedUCPH @koebenhavns_uni @Oxford_NDPH

What a fantastic week with these wonderful people @Oxford_NDPH #MScClinicalTrials #AcademyESC @escardio @DjawidHashemi @cristina_gavina @MLHandoko @FH_Verbrugge @A_FelixOliveira @TorBiering @Carlosomendivi1 @JulePinter @pkumarathurai @BoldiKovacsMD @PraveenRoyMD

The Godfather of randomized trials, Sir Richard Peto, giving an amazing talk about ‘Interpreting large-scale randomised evidence’ at the MSc in RCT’s at @UniofOxford @FH_Verbrugge @BoldiKovacsMD @DjawidHashemi @aayshacader @pkumarathurai @RichardHaynes3 @CopCard @CIRL_DK

Iconic slide on subgroup analyses with the icon himself! #RichardPeto #RCT #ISIS2 ♎♊ ⭕ Fantastic first day @Oxford_NDPH #MScClinicalTrials @DjawidHashemi @cristina_gavina @BoldiKovacsMD @TorBiering @FH_Verbrugge @MLHandoko @JulePinter @pkumarathurai @PraveenRoyMD

@DjawidHashemi @berlinnovation @dhzberlin @ChariteBerlin @CardiacStats @dzhk_germany @YoungDZHK @YoungDgk Congrats 😊

🎉🍾🥳 Got it! Admitted to the @berlinnovation Digital Clinician Scientist programme! 3 yrs funding, dedicated research⏱ & support. Collaborative project @dhzberlin and @ChariteBerlin! Thanks to everyone supporting me with💡, application & presentation feedback! @CardiacStats

@TorBiering Congratulations, my friend 👏😊

Yesterday was an extraordinary day for our group working on pragmatic randomized trials using the 🇩🇰 nationwide registries. We launched the DANFLU-1 trial which aim to randomize 40000 participants to receive either a high or a standard dose flu vaccine clinicaltrials.gov/ct2/show/NCT05…

#EMPEROR-Preserved trial: empagliflozin reduces the risk of a composite of #cardiovascular death or hospitalisation for #heartfailure in patients with #HFpEF with or without #diabetes #ESCCongress

#EMPERORPreserved Top Line 🔥 Empagliflozin ↓ risk of CVd+HF hosp in 5,988 pts HFpEF Awaiting #ESC2021 LBCT together w #EMPERORPooled (n=9,718) across LVEF spectrum (primary EP of kidney events) Bravo @JavedButler1 #StefanAnker @FaiezZANNAD @Filippatos prnewswire.com/news-releases/…

Beyond Heart Rate. Consistent lack of effect of GLP-1RA on diastolic function parameters in PPL with type 2 #diabetes and CAD pubmed.ncbi.nlm.nih.gov/33413428/

Important for us cardiologists to see the force behind this bleed in LV free wall rupture after STEMI. Thank you @ShariqShamimMD and thank you #cardiotwitter for the opportunity to share such insight. @escardio @beatscaduk @SCAI @mirvatalasnag @Drroxmehran @mmamas1973

Today, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet hubs.ly/H0r7gh50

The @US_FDA authorised remdesivir for COVID-19 on the basis of 1 outcome from the NIAID trial. This outcome was switched, the trial is unpublished, and we have no good evidence remdesivir reduces mortality. Our piece for @CebmOxford @NDevito1 @JKAronson cebm.net/covid-19/the-f…

Researcher promoting red meat, sugar failed to disclose industry ties—again arstechnica.com/science/2020/0…

DAPA HF: 4744 pts w/HFrEF w/or w/o diabetes rand to SGLT2i dapaglifozin vs placebo. Med 18 mo FU. CV death, HF hosp or urgent HF visit reduced by 26%, p<0.0001. Sign decrease in CV death as well as HF events. All death decr. Benefits identical in pts w/& w/o DM. New Rx for HFrEF!

The HUAWEI Heart study found continuous home monitoring w/ mobile health devices equipped w/ PPG technology could be a feasible approach for screening & early detection of #AFib in large populations. #ESCCongress #JACC fal.cn/33JCc

Very cool navigation feature in the #ESCcongress2019 app

DAPA-HF trial at #ESCCongress: significant reduction of events in HFrEF patients by dapagliflozine. Half of the 5744 pts had diabetes, the others did not: same effect in both groups. SGLT2 inhibitors just better diuretics or the "statins of HF"? @escardio #cardiotwitter

Fox News tried coming after Denmark's social safety net. This Danish politician's retort was legendary.